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SUMMARY
Culture for Bordetella pertussis (B. pertussis) is the traditional gold standard for laboratory
diagnosis of pertussis but is insensitive, especially later in the course of illness and in vaccinated
persons. Interpretation of serology is limited by the lack of an appropriate reference standard. An
outbreak of pertussis in a crowded boarding-school dormitory allowed evaluation of laboratory
correlates of infection. Questionnaires, serum samples and throat swabs were collected from
members of the exposed group. Serum samples from unexposed controls of a similar age group
were used for comparison. B. pertussis PCR was performed on throat swabs, and sera were tested
for IgA antibodies against whole-cell (WC) B. pertussis antigen and IgG antibodies to pertussis
toxin (PT). The Centers for Disease Control and Prevention definition for pertussis was used to
define clinical cases. We evaluated the use of a previously published cut-off for PT IgG of 125
EIA units (EU)/ml. Completed questionnaires were obtained from 115 students, of whom 85
(74%) reported coughing symptoms, including 32 (28%) who met the clinical case definition for
pertussis. B. pertussis was detected by PCR in 17 (15%) and WC IgA in 22 (19%) students ;
neither correlated with symptoms, but dormitory of residence strongly predicted PCR status. The
mean PT IgG geometric mean concentration, in this situation of high pertussis exposure,
correlated with severity of symptoms and was significantly higher in both symptomatic and
asymptomatic children exposed during the outbreak (P<0.001) than in control children. A
cut-off for PT IgG of 125 EU/ml was too high in an outbreak situation to be sensitive enough to
identify pertussis cases. A case of pertussis in a crowded boarding-school dormitory resulted
rapidly in an outbreak. Serology and PCR were useful in identifying the outbreak and
commencing disease control measures. The use of serology has mostly been evaluated in
community serosurveys, where it is not possible to determine if immunity reflects vaccination,
asymptomatic disease or symptomatic disease. This outbreak gave us the opportunity to evaluate
the value of serology and PCR in the presence of confirmed exposure to pertussis.
INTRODUCTION
Diagnosis of pertussis is problematical, particularly
in adolescents and adults in whom symptoms are
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atypical and presentation is often delayed [1–4].
Culture of Bordetella pertussis is the traditional gold
standard for diagnosis, but is less sensitive in older
children and adolescents than in infants because
of delayed presentation and previous immunity.
Detection of B. pertussis DNA by polymerase chain
reaction (PCR) partially overcomes these problems
but also has limited sensitivity, especially with late
presentations [5]. Serology is increasingly used to di-
agnose pertussis in older age groups, but cannot dis-
tinguish reliably between natural and vaccine-induced
immunity. Delay in diagnosis also limits the utility of
paired sera to detect an antibody rise.
Both natural immunity and vaccination result in
protection for a limited period of time [6]. Exposure to
B. pertussis is generally believed to be frequent, with
associated boosting of antibody levels. However,
detection of elevated titres to one or more pertussis
antigens, most commonly pertussis toxin (PT) in sero-
epidemiological studies may have limited correlation
with symptom severity [7–10].
A pertussis outbreak in a boarding school for boys
with an enrolment of over 900 students, in Sydney,
Australia, and a contemporaneous serological study
in a population of similar age without known per-
tussis exposure, offered an opportunity to examine
many of these issues. The boys were living in a crow-
ded dormitory, such that exposure to B. pertussis
from coughing residents over the period prior to in-
vestigation was assumed to be universal. The control
students, of similar age, were participants in a vaccine
trial from other schools.
The aim of our study was to describe the outbreak
and examine the performance of various diagnostic
tests for pertussis, in the context of uniform, extensive
exposure to B. pertussis and to compare serological
parameters with an age-matched control group.
METHODS
Outbreak investigation
The first pertussis case in a year 8 student in the
boarding school was notified on 10 November 2000
and three more suspected cases, also in year 8, were
notified on 20 November. A subsequent outbreak
investigation showed that the majority of cases were
among year 8 students, aged 13–15 years, with the
suspected index case developing symptoms on 10
October 2000. The detailed outbreak investigation
was confined to year 8 boarders, as there were few
cases outside of this group. Erythromycin prophylaxis
was initially given only to close friends of and stu-
dents in neighbouring beds to affected students, but
was extended to all year 8 students over the period
27–30 November. Pupils were asked to complete a
written questionnaire and a throat swab and blood
sample were taken at the same time. A second blood
sample was taken 3 months later.
The Centers for Disease Control and Prevention
(CDC) case definition for pertussis [11] was used to
define a clinical case. This definition requires o2
weeks’ cough plus one or more of : paroxysms, or
post-tussive vomiting, or inspiratory whoop (without
any other cause), or epidemiological link to a labora-
tory-confirmed pertussis case. Children who had a
cough but did not meet the CDC definition were
also counted in the epidemic curve, as they are
likely to be true cases in the context of a confirmed
outbreak.
Survey
An initial questionnaire was administered to all
students on 23 November, asking about socio-
demographic details, cough symptoms in the past
4 weeks, exposure to students with cough, dormitory
and study arrangements within the boarding school,
past medical history and vaccination history.
Students were asked to complete the questionnaires
themselves, but received assistance from public health
nurses if necessary. As the school closed for the
extended summer vacation on 7 December, a follow-
up questionnaire addressing the resolution of the
cough, side-effects of erythromycin and childhood
immunization status was sent to parents in mid-
December 2000. Parents were asked to consult official
immunization records if possible. Parental recall of
immunization history was poor, with a response of
‘unknown/immunization record not available ’ in
60% (73/122) of cases. Therefore, immunization
history was obtained from school records.
Laboratory tests
Written, informed consent was obtained from all
parents or guardians. A team of doctors and nurses
visited the school and collected throat swabs and
10 ml of blood from the students on 23 November
2000. A second visit was made on 9 March 2001 to
collect convalescent sera.
Children aged 12–14 years participating in a
separate study of cough prevalence, combined within
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a hepatitis B vaccine immunogenicity study [12], were
used as community controls. This study involved a
convenience sample from four secondary schools in
Sydney of 440 high-school students, whose mean age
was 13¡0.4 S.D., comparable to the outbreak popu-
lation. Sera were collected in November 2000, and
parents completed a questionnaire concerning cough
history in the previous 12 months and pertussis
immunization history.
Serology
IgA against whole-cell pertussis antigen (WC IgA)
Sera were tested for IgA, using B. pertussis IgA
ELISA kit (PanBio, Australia, catalogue no. BPA-
300), in which the antigen is an extract of WC B.
pertussis. The manufacturer’s instructions were fol-
lowed. Test and control sera were diluted 1:100. Cut-
off calibrators were tested in triplicate. After addition
of reagents, incubation and washing, results were
calculated by dividing the optical density (OD) of the
serum by the mean OD of the cut-off calibrator, and
multiplying this by 10. Interpretation, according to
manufacturer’s recommendations, was as follows:
<9 units negative, ‘no evidence of recent infection’,
repeat after 7–14 days;>11 units positive, ‘ suggests a
recent infection’ ; 9–11 units equivocal. Any equivocal
results, which are uncommon, were repeated and
classified as positive, negative or equivocal, according
to the result of the second test.
IgG against pertussis toxin (PT IgG)
PT IgG levels were measured at the University of
Palermo, Italy, by enzyme-linked immunosorbent
assay (ELISA), which is a standardized assay for
pertussis within the European Sero-Epidemiology
Network (ESEN) [13, 14]. Due to cost and other
logistic issues, not all serum samples could be
tested. A random, blinded selection of 95 out of 114
initial samples and 38 out of 56 paired samples
were tested.
Polymerase chain reaction (PCR)
Throat swabs were taken from all students who
completed the first questionnaire on 23 November for
pertussis PCR testing, at the Centre for Infectious
Diseases and Microbiology, Institute of Clinical
PathologyandMedicalResearch,WestmeadHospital,
Australia. Throat swabs were processed using the
Roche Respiratory Specimen Preparation Kit (Roche,
Basel, Switzerland; catalogue no. 0756903) according
to manufacturer’s instructions. Samples were stored at
x20 xC prior to testing. PCR was performed using
primers described by Glare et al., which target a
repetitive sequence in B. pertussis and generate a
153 bp amplicon [15]. The single amplification PCR
conditions were optimized in-house. Final concen-
trations of reagents in the reaction mix were: 10 mM
Tris–HCl (pH 8.3) ; 50 mM KCl; 1.5 mM MgCl2 ;
0.01% gelatin ; 100 mM dNTPs; 200 nM BP1 and BP2
primers; 1.0 U AmpliTaq Gold DNA polymerase
(PerkinElmer, Mulgrave, Victoria, Australia). The
thermal profile for the reaction was: 95 xC for 10 min,
followed by 50 cycles of 96 xC for 10 s, 63 xC for 1 min
and 72 xC for 30 s with a final extension step at 72 xC
for 5 min. Controls for monitoring specimen in-
hibition (50/50 mixture of positive control and speci-
men), episodes of contamination and assay sensitivity
were included in each assay. Amplicons were ident-
ified using agarose gel electrophoresis and ethidium
bromide staining. An amplicon of exactly the same
length to that of the positive control was read as a
positive result.
Data analysis
On the basis of the information provided in the
questionnaires, pupils were placed into one of three
clinical categories : those with no cough; those who
satisfied the US CDC clinical case definition for per-
tussis ; and those reporting a cough but not meeting
the case definition [16]. The CDC clinical case defi-
nition for pertussis is cough for 14 days or longer,
accompanied by one or more of bouts of coughing,
post-cough vomiting or inspiratory whoop. For the
purpose of the analysis, individuals who reported they
were still coughing at the time of the second ques-
tionnaire were assumed to have stopped coughing on
that day.
Serological results (for PT IgG) were transformed
using log to the base 10, and geometric mean con-
centration (GMC) [with 95% confidence interval
(CI)] was used as measure of central tendency. As the
distribution of serological results remained non-
normal after log transformation, non-parametric
statistical tests were used. The Kruskal–Wallis H test
was used to test the statistical significance of differ-
ences between PT IgG GMC in the three clinical cat-
egories. The Mann–Whitney U test was used to test
the statistical significance of differences between PT
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IgG GMC of the symptomatic and asymptomatic
groups. Wilcoxon matched-pairs signed rank sum was
used to test the statistical significance of differences in
PT IgG GMCs between paired serum samples.
The statistical significance of differences in pro-
portions was tested using a x2 test or Fisher’s exact
test if any cells in 2r2 tables had an expected
frequency of<5.
A cut-off of 125 EIA units (EU)/ml of PT IgG was
used todefine recent pertussis infection, as describedby
De Melker et al. [17]. De Melker found that a single
sample of anti-PT IgG of >125 Italian EU/ml was
indicative of recent (within 6 months) infection with
B. pertussis. Because both de Melker’s study and ours
used the ESEN standardized assay, the value of this
cut-off can be compared directly between the two
studies.
Univariate and multivariate logistic regression
analysis (Egret software [18]) was used to determine
predictors of meeting the CDC clinical case definition
for pertussis.
RESULTS
The first four reported cases were all boarders in a
relatively crowded dormitory. There were 122 boy
boarders in three dormitories, all aged between 13 and
15 years (median 14.2 years). The close proximity of
beds in the dormitories is illustrated by Figure 1.
Completed questionnaires were obtained for 115 out
of 122 boys (94%). All students boarded for at least
two nights per week in one of three 30- to 40-bed
dormitories with 75 out of 115 (65%) boarding seven
nights a week. The index case and the other three
reported cases boarded in Dormitory A.
A throat swab (for PCR) was obtained from 114
out of 115 boys, at least one blood sample was tested
in 95 out of 115 and paired blood samples were tested
in 31% (38/122).
The epidemic curve is shown in Figure 2. The
first case occurred on 10 October, and the peak of
cases was in November. Of the 115 who completed
questionnaires, 74% (85/115) reported coughing
symptoms over the period covered by the two ques-
tionnaires. The overall mean duration of coughing
symptoms was 13 days, and 32 individuals (28%) met
the clinical case definition for pertussis. Of these, 15
students were in Dormitory A, and nine and eight
students respectively in adjacent dormitories B and C.
The median interval from onset of coughing symp-
toms to first serum specimen was 19 days (range 2–41
days). The median interval from onset of symptoms to
second serum specimen was 113 days (range 100–134
days).
There was no significant association between fulfil-
ling the clinical case definition for pertussis and the
following variables : previous vaccination against
pertussis (P=0.11), reporting a previous diagnosis of
pertussis (P=0.68) or having ever been diagnosed
with asthma (P=0.17).
Seventeen pupils (15%) had a positive PCR result
and 22 (19%) had positive tests for IgA antibody
to WC pertussis antigen (there were no equivocal
results). There was no significant difference between
the clinical categories in the proportion PCR- or WC
IgA-positive (Table). A positive PCR result appeared
to be more likely when the testing was done close to
the date of symptom onset, including some (n=6) that
were positive before symptom onset. The odds ratio
for a positive PCR result for tests taken within 7 days
of symptom onset was 2.7 (95% CI 0.59–14,
P=0.15). There was no significant difference in the
Fig. 1. One of the affected dormitories.
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mean IgG titres between PCR-positive (89.8 EU) and
PCR-negative (104.5 EU) subjects.
When the first serum specimen only (n=95) was
considered, the mean PT IgG concentration differed
significantly between clinical groups, increasing from
15 in asymptomatic children to 70 in those who met
the CDC case definition for pertussis (Table). The
mean PT IgG concentration in those who had a cough
but did not meet the clinical case definition was
also higher than in those who had no cough, but this
difference was not statistically significance (P=0.07).
Paired serum specimens were available from 10
boys, who met the CDC clinical case definition for
pertussis. In these cases, the mean PT IgG concen-
tration of the first sample was significantly higher
(P=0.01) than that of the second. For the other
clinical categories, there was no significant difference
between the mean PT IgG concentrations in the first
and second samples.
Serum samples taken in November 2000 were
available from 287 control children aged 12–15 years
who reported that they had not had a coughing illness
lasting 14 days or more in the preceding year. The age
of the control group (median 14.0 years) was slightly,
but significantly younger than that of the outbreak
group (median age 14.2 years) (P<0.001). Forty-
seven per cent of the control group were female, whilst
all of the outbreak group were male.
When compared to the PT IgG GMC in the control
group, the proportions of students in the outbreak
group with a GMC greater than two standard
deviations above the control group value were: 54%
(13/24) in the group who met the CDC case definition
for pertussis, 32% (14/44) in the group with cough
who did not meet the CDC definition, and 0% (0/22)
in the asymptomatic group.
When compared to the 287 control subjects, the PT
IgG GMC was significantly higher in all clinical
groups involved in the outbreak (P<0.001, Fig. 3).
The GMC of the control group was 2.7; the asymp-
tomatic outbreak group, 17.4; the outbreak group
with cough, 33; and the outbreak group who met the
CDC case definition, 71. Finally, 17 out of 95 (18%)
of the boarding-school cohort had PT IgG levels
>125 EU/ml, compared to only 3 out of 287 (1%)
in the control group (OR 20.6, 95% CI 5.5–91,
P<0.0001).
In univariate analysis, the only significant predictor
of a positive PCR result was residing in dormitory A,
in which the index case and the largest number of
clinical cases resided (OR 4.7, 95% CI 1.4–15.3). Age,
PT IgG >125 EU/ml and past pertussis vaccination
were not significant predictors of a positive PCR
result. In multivariate logistic regression, dormitory
of residence remained the only significant variable
(data not shown).
DISCUSSION
School children are an important risk group for per-
tussis transmission, with 18 out of 20 outbreaks of
pertussis over one year in one US state occurring in
Table. Results of diagnostic tests by clinical category
Diagnostic test
Clinical cough category
P valueNo cough
Cough, not fulfilling
CDC case definition
(n=53)
Cough, fulfilling
CDC case definition
(n=32)
PCR+ve/ tested
(%)
6/30 (20) 4/52 (8) 7/32 (22) 0.14#
WC IgA+ve/
tested (%)
5/23 (22) 10/48 (21) 7/24 (29) 0.64#
PT IgG>125
EU/tested (%)
0/23 (0) 6/48 (12) 8/24 (33) <0.01#
PT IgG GMC*
(95% CI)
15 (11–21) 31 (21–47) 70 (37–1323) 0.001$
WC, whole-cell pertussis antigen; PT, pertussis toxin ; GMC, geometric mean concentration; EU, EIA units.
CDC case definition is : cough for 14 days or longer, accompanied by one or more of bouts of coughing, post-cough vomiting,
inspiratory whoop or an epidemiological link to another case.
* Geometric mean concentration, first serum specimen.
# x2 test.
$ Kruskal–Wallis test.
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schools [19]. This potential for pertussis outbreaks
exists even in highly vaccinated school populations
[20, 21]. In the special group of adolescents reported
here, who were exposed to pertussis in a crowded,
closed environment, 74% developed coughing symp-
toms, and 28% met a standard case definition for
pertussis. There was a clear correlation between the
severity of symptoms and PT IgG antibody levels.
The GMC was significantly higher in the outbreak
population compared with community controls,
and within the outbreak population, it increased with
increasing severity of clinical symptoms.
In a non-epidemic period, using a population sam-
ple, de Melker et al., in The Netherlands, found that a
single serum anti-PT IgG level of >125 EU/ml was
indicative of recent pertussis, but levels decayed rap-
idly, over time, with high levels lasting an average of
4.4 months [17]. The low number of subjects in this
study with a PT Ig titre over this cut-off in this setting
suggests that a lower cut-off may be appropriate in an
outbreak situation, as the pre-test probability of in-
fection was very high. The cut-off suggested by de
Melker might be more appropriate for a general
population survey than for a universally exposed
subpopulation in an acute outbreak.
As in our study, during an institutional outbreak
of pertussis in The Netherlands, only a minority of
people with clinical pertussis had positive PCR or
cultures, but a high proportion (85%) had serological
evidence of pertussis [22]. Others have found that
PCR for pertussis is significantly more sensitive
than culture and highly specific, in that it is consist-
ently negative in healthy, unexposed controls [15, 23].
Positive PCR results in exposed subjects without
cough, indicates subclinical infection. The sensitivity
of PCR for detecting B. pertussis in this study was
limited by the timing of the available samples, but
our results show that PCR was more likely to be
positive when specimens were collected within a week
(before or after) onset of symptoms. This is a similar
limitation to culture, but the advantage of PCR
is the simpler methods for handling of specimens.
Univariate analysis also showed that a positive PCR
result was predicted by dormitory of residence, with
students in the same dormitory as the index case being
almost five times more likely to have a positive PCR
result. However, the same analysis showed that PCR
status was not predicted by serology or clinical
symptoms.
An IgA assay against WC pertussis antigen was
the only commercially available serological test for
pertussis diagnosis at the time of this study. It is
widely used in Australia for diagnosis of pertussis,
especially in older children and adults. We have
previously demonstrated that the test is relatively
insensitive but, in individual cases, has a high positive
predictive value for coughing illness, which fulfils
the case definition for pertussis [24]. However, in this
highly exposed population, it did not discriminate
between symptomatic and subclinical infection.
The study had several other limitations. First, not
all sera were tested for PT IgG, introducing the
potential for bias. However, they were selected ran-
domly for testing, thereby reducing this risk. Second,
there were some differences between the control and
outbreak groups, in age, gender and sample time-
frame, which may bias the results. The controls
were on average 1–2 years older than the outbreak
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population, were of mixed gender and sera were
collected a month earlier. If there was less pertussis
during that time, the effect of this may be to over-
estimate the difference in the GMC of PT IgG
between the outbreak and control groups. Third, it
was not possible to obtain a reliable immunization
history for 60% of the children, whose parents did
not have records, and could not recall details of pre-
vious vaccinations. These children were born between
1985 and 1987, when WC pertussis vaccine was used
and only y70% of infants received three or more
doses, but without accurate data, we were unable to
examine the relationship between vaccination status
and risk of disease.
The early diagnosis of pertussis in this school by the
laboratory methods described, and the prompt in-
itiation of disease control strategies such as isolation
and antibiotic use, may have prevented the outbreak
from spreading outside the boarding school and
beyond the affected age group.
The use of serology has mostly been evaluated in
community serosurveys, where it is not possible to
determine if evidence of serological immunity reflects
vaccination, asymptomatic disease or symptomatic
disease. Many studies of diagnostic tests for pertussis
have relied on past history of exposure to pertussis or
have sought to differentiate causes of non-specific
coughing illness [5, 8, 17, 25]. This outbreak gave us
the rare opportunity to evaluate the value of serology
and PCR in the presence of confirmed, intense and
universal exposure to pertussis. These data, showing
the correlation between elevated serological titres
and clinical symptoms and evidence of asymptomatic
pertussis infection, as demonstrated by PCR, will
contribute to interpretation of findings in population-
based serosurveillance studies of pertussis trans-
mission.
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